Kate Priestman
Directeur/Membre du Conseil chez OXFORD NANOPORE TECHNOLOGIES PLC
Fortune : 32 192 $ au 31/05/2024
Postes actifs de Kate Priestman
Sociétés | Poste | Début | Fin |
---|---|---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Directeur/Membre du Conseil | 13/07/2023 | - |
Independent Dir/Board Member | 13/07/2023 | - | |
CSL LIMITED | Corporate Officer/Principal | 01/09/2023 | - |
GlaxoSmithKline Intellectual Property Management Ltd.
GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property Management Ltd. is a British biopharma company focused on unlocking the science of the immune system to understand how the body's defence system reacts to disease. The company is based in Brentford, UK. GSK offers a portfolio of brands and educational resources for patients and healthcare professionals. GSK has recently acquired TESARO, an oncology-focused company, and has launched a tracing programme in partnership with ProSearch to reunite lost shareholders with unclaimed entitlements. | Directeur/Membre du Conseil | - | - |
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
GlaxoSmithKline Intellectual Property (No. 2) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. The British company combines human genetics, genomics, and advanced technologies to develop more effective vaccines and medicines. This privacy notice applies to any individual who is a current or former registered shareholder of GSK Plc. The company's purpose is to unite science, technology, and talent to get ahead of disease together. 2) Ltd. is a biopharma company founded in 2012. | Directeur/Membre du Conseil | 09/12/2016 | - |
Glaxosmithkline Intellectual Property Development Ltd.
Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British biopharma company founded in 2012. The company is based in Middlesex, UK. GlaxoSmithKline Intellectual Property Development unites science, technology, and talent to get ahead of disease together. The company recently completed a transaction to combine its consumer healthcare businesses into a new Joint Venture. | Directeur/Membre du Conseil | 09/12/2016 | - |
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GlaxoSmithKline Intellectual Property (No. The company is based in Middlesex, UK and engages in the development, enhancement, maintenance, protection, and exploitation of intellectual properties. 3) Ltd. is a subsidiary of GSK Plc. | Directeur/Membre du Conseil | 24/07/2018 | - |
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. An apprenticeship program is offered to students who want to start their GSK career from day one by learning from industry experts. GSK also provides advice to shareholders about how to be aware of share scams that typically come from overseas-based brokers. Explore the British company's social media channels and access their social media community guidelines. 4) Ltd. is a company founded in 2018 that unites science, technology, and talent to get ahead of disease. | Directeur/Membre du Conseil | 11/12/2018 | - |
Royal Botanical Gardens | Directeur/Membre du Conseil | - | - |
Historique de carrière de Kate Priestman
Anciens postes connus de Kate Priestman
Sociétés | Poste | Début | Fin |
---|---|---|---|
GlaxoSmithKline Intellectual Property Ltd.
GlaxoSmithKline Intellectual Property Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property Ltd. is a British biopharma company that prioritizes research into vaccines and medicines across its four core therapy areas. The company is based in Brentford, UK. GSK unites science, technology, and talent to discover and develop new products with a purpose to get ahead of disease together. | Directeur/Membre du Conseil | - | 28/10/2022 |
░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Statistiques
Internationale
Royaume-Uni | 10 |
Australie | 2 |
Opérationnelle
Director/Board Member | 8 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Sectorielle
Commercial Services | 5 |
Health Technology | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
GSK PLC | Health Technology |
CSL LIMITED | Health Technology |
Entreprise privées | 7 |
---|---|
GlaxoSmithKline Intellectual Property Management Ltd.
GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property Management Ltd. is a British biopharma company focused on unlocking the science of the immune system to understand how the body's defence system reacts to disease. The company is based in Brentford, UK. GSK offers a portfolio of brands and educational resources for patients and healthcare professionals. GSK has recently acquired TESARO, an oncology-focused company, and has launched a tracing programme in partnership with ProSearch to reunite lost shareholders with unclaimed entitlements. | Commercial Services |
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
GlaxoSmithKline Intellectual Property (No. 2) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. The British company combines human genetics, genomics, and advanced technologies to develop more effective vaccines and medicines. This privacy notice applies to any individual who is a current or former registered shareholder of GSK Plc. The company's purpose is to unite science, technology, and talent to get ahead of disease together. 2) Ltd. is a biopharma company founded in 2012. | Commercial Services |
GlaxoSmithKline Intellectual Property Ltd.
GlaxoSmithKline Intellectual Property Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property Ltd. is a British biopharma company that prioritizes research into vaccines and medicines across its four core therapy areas. The company is based in Brentford, UK. GSK unites science, technology, and talent to discover and develop new products with a purpose to get ahead of disease together. | Commercial Services |
Glaxosmithkline Intellectual Property Development Ltd.
Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British biopharma company founded in 2012. The company is based in Middlesex, UK. GlaxoSmithKline Intellectual Property Development unites science, technology, and talent to get ahead of disease together. The company recently completed a transaction to combine its consumer healthcare businesses into a new Joint Venture. | Finance |
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GlaxoSmithKline Intellectual Property (No. The company is based in Middlesex, UK and engages in the development, enhancement, maintenance, protection, and exploitation of intellectual properties. 3) Ltd. is a subsidiary of GSK Plc. | Commercial Services |
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. An apprenticeship program is offered to students who want to start their GSK career from day one by learning from industry experts. GSK also provides advice to shareholders about how to be aware of share scams that typically come from overseas-based brokers. Explore the British company's social media channels and access their social media community guidelines. 4) Ltd. is a company founded in 2018 that unites science, technology, and talent to get ahead of disease. | Health Technology |
Royal Botanical Gardens |
- Bourse
- Insiders
- Kate Priestman
- Expérience